These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21748243)

  • 1. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
    Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
    Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.
    Hashim Z; Zarina S
    Clin Biochem; 2007 Jun; 40(9-10):705-9. PubMed ID: 17466963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
    Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
    J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
    Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
    Serin O; Konukoglu D; Firtina S; Mavis O
    Horm Metab Res; 2007 Mar; 39(3):207-11. PubMed ID: 17373636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
    Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
    Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in white coat hypertension; role of paraoxonase.
    Uzun H; Karter Y; Aydin S; Curgunlu A; Simşek G; Yücel R; Vehiyd S; Ertürk N; Kutlu A; Benian A; Yaldiran A; Oztürk E; Erdine S
    J Hum Hypertens; 2004 Jul; 18(7):523-8. PubMed ID: 14985779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia.
    Uzun H; Benian A; Madazli R; Topçuoğlu MA; Aydin S; Albayrak M
    Gynecol Obstet Invest; 2005; 60(4):195-200. PubMed ID: 16088195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment.
    Baskol G; Atmaca H; Tanriverdi F; Baskol M; Kocer D; Bayram F
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):522-6. PubMed ID: 17853336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
    Samy W; Hassanian MA
    Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of oxidative stress and antioxidant defenses in Buerger disease and atherosclerotic peripheral arterial occlusive disease.
    Arslan C; Altan H; Beşirli K; Aydemir B; Kiziler AR; Denli S
    Ann Vasc Surg; 2010 May; 24(4):455-60. PubMed ID: 19128930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.
    Yıldırım S; Akar S; Kuyucu M; Yıldırım A; Dane S; Aygül R
    Cell Biochem Funct; 2011 Oct; 29(7):549-54. PubMed ID: 21755523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitis.
    Kodydkova J; Vavrova L; Stankova B; Macasek J; Krechler T; Zak A
    Pancreas; 2013 May; 42(4):614-21. PubMed ID: 23558240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
    Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.